Form 4: ProAssurance Executive Granted New Equity Awards

Sentiment:

Executive Equity Grant


ProAssurance Corporation's Executive Vice-President, Secretary & General Counsel, Jeffrey P. Lisenby, was granted 23,720 Restricted Stock Units, vesting over three years.

Summary

  • Jeffrey P. Lisenby, Executive Vice-President, Secretary & General Counsel of ProAssurance Corporation, received a grant of 23,720 Restricted Stock Units (RSUs) on January 7, 2026.
  • These new RSUs will vest pro rata in one-third increments in 2027, 2028, and 2029, conditional on continuous employment with ProAssurance or its subsidiaries.
  • Vesting can accelerate under specific conditions including death, disability, or 'Good Reason' termination, as defined in Lisenby's employment agreement, or by action of the Compensation Committee.
  • The RSUs will be settled in ProAssurance Common Stock and a cash portion approximately equal to federal, state, and local taxes.
  • Following this transaction, Lisenby beneficially owns a total of 60,741 Restricted Share Units, including previously granted RSUs from 2014 and 2024 plans.

Sentiment

Score: 7

Explanation: The filing reports a routine executive equity grant, which is a positive for executive retention and alignment with shareholder interests, but does not indicate any extraordinary operational or financial news.

Positives

  • The grant of 23,720 Restricted Stock Units to a key executive aligns management's long-term interests with shareholder value.
  • The equity award serves as an incentive for long-term retention and performance, with vesting tied to continuous employment.
  • Vesting acceleration clauses provide some security for the executive under specific termination events such as death, disability, or 'Good Reason'.

Negatives

  • The RSUs are contingent and do not represent immediate ownership or liquidity, as they vest over several years.
  • The ultimate value of the award is dependent on the future stock price of ProAssurance Corporation, introducing market risk.

Risks

  • The primary risk for the reporting person is the forfeiture of unvested RSUs if employment terminates before vesting dates, outside of specified acceleration conditions.
  • The value of the vested shares is subject to market fluctuations of ProAssurance Corporation's common stock.

Future Outlook

The grant of Restricted Stock Units indicates a long-term incentive strategy for executive retention and performance, with vesting scheduled through 2029, aligning the executive's future compensation with the company's stock performance.

Management Comments

  • Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of ProAssurance Corporation common stock, issuable from the ProAssurance Corporation 2014 Equity Incentive Compensation Plan or 2024 Equity Incentive Plan.
  • The RSUs will vest pro rata in increments equal to one-third of the total award in each of the years [specific years] provided the reporting person remains continuously employed by ProAssurance or one of its subsidiaries until each vesting date.
  • Vesting will accelerate upon termination of employment as the result of (i) death; (ii) disability; or (iii) Good Reason, as defined in the reporting person's employment agreement with ProAssurance Corporation, or by action of the Compensation Committee of the ProAssurance Corporation Board of Directors.
  • The RSUs will be settled in shares of ProAssurance Common Stock and in cash, with the cash portion being approximately equal to the federal, state, and local taxes.

Industry Context

This RSU grant is a standard practice in executive compensation across many industries, particularly in the financial and insurance sectors, to incentivize long-term commitment and align executive interests with shareholder returns. It reflects a common strategy for talent retention and performance motivation.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a long-term incentive is a widely adopted practice, comparable to compensation structures at peer insurance companies such as The Travelers Companies, Inc. (TRV) or Chubb Limited (CB).
  • The three-year pro-rata vesting schedule is typical for executive equity awards, aiming to retain key personnel over a sustained period, similar to programs seen at companies like Aflac Incorporated (AFL) or Principal Financial Group (PFG).
  • Acceleration clauses for death, disability, or 'Good Reason' are standard provisions in executive employment agreements, offering protection and common in the industry.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantJeffrey P. Lisenby granted a Power of Attorney to Marta E. Garrett, J. Kenneth McEwen, Lee M. Pope, and Kathryn A. Neville to prepare, execute, and submit SEC Forms 3, 4, and 5 on his behalf.2019-05-22Streamlines the process for executive compliance with Section 16(a) reporting requirements, ensuring timely and accurate filings.

Stakeholder Impact

  • Shareholders: The RSU grant aligns executive incentives with long-term shareholder value creation, potentially leading to better company performance and stock appreciation.
  • Employees: Reinforces the company's commitment to executive retention and a structured compensation framework.

Next Steps

  • Continued employment of Jeffrey P. Lisenby with ProAssurance Corporation.
  • Vesting of the granted Restricted Stock Units in 2027, 2028, and 2029, contingent on employment.
  • Settlement of vested RSUs in common stock and cash for taxes.

Key Dates

DateDescription
2019-05-22Date Power of Attorney was executed by Jeffrey P. Lisenby.
2024-01-01Approximate start of vesting for 3,981 RSUs (one-third in 2024, 2025, 2026).
2025-01-01Approximate start of vesting for 15,372 RSUs (one-third in 2025, 2026, 2027).
2026-01-01Approximate start of vesting for 17,668 RSUs (one-third in 2026, 2027, 2028).
2026-01-07Date of acquisition of 23,720 Restricted Stock Units by Jeffrey P. Lisenby.
2026-01-08Date the Form 4 was signed by Lee M. Pope, POA.
2027-01-01Approximate start of vesting for 23,720 RSUs (one-third in 2027, 2028, 2029).

Recommendation

hold

This Form 4 filing details a routine executive compensation event (an RSU grant) and does not contain information that would fundamentally alter the investment thesis for ProAssurance Corporation. While it signals continued executive alignment, it's not a catalyst for a 'buy' or 'sell' recommendation. Investors should continue to hold based on broader company fundamentals and market conditions, rather than this specific insider transaction.

Keywords

ProAssurance, PRA, Restricted Stock Units, RSU, Equity Incentive, Executive Compensation, SEC Form 4, Insider Transaction, Stock Grant, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.